Color-coded automated signal intensity curves for detection and characterization of breast lesions: Preliminary evaluation of a new software package for integrated magnetic resonance-based breast imaging

Investigative Radiology

Volumn 40, Issue 7, 2005, Pages 448-457

  Pediconi, Federica ^a   Catalano, Carlo ^a   Venditti, Fiammetta ^a   Ercolani, Mauro ^b   Carotenuto, Luigi ^b   Padula, Simona ^a   Moriconi, Enrica ^a   Roselli, Antonella ^a   Giacomelli, Laura ^a   Kirchin, Miles A ^c   Passariello, Roberta ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Tecnobiomedica SpA   (Italy)

^c Bracco Imaging SpA   (Italy)

Author keywords

Breast MR; Breast neoplasms; Computers; Diagnostic aid; Image processing; Magnetic resonance (MR); Magnetic resonance (MR) contrast enhancement; MR

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOBENIC ACID;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BOLUS INJECTION; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; MALIGNANT NEOPLASTIC DISEASE; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE MAMMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING; TUMOR VOLUME;

EID: 20844450943     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000167427.33581.f3     Document Type: Article

References (37)

1. Jemal A, Tiwari RC, Murray T, et al. American Cancer Society. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8-29.
2. Samuels JR, Haffty BG, Lee CH, et al. Breast conservation therapy in patients with mammographically undetected breast cancers. Radiology. 1992;185:425-427.
3. Leibman AJ, Kruse B. Breast cancer: mammographic and sonographic findings after augmentation mammoplasty. Radiology. 1990;174:195-198.
4. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis and staging of breast cancer. Radiology. 2001;220:13-30.
5. Conrad C, Corfitsen MT, Gyldholm N, et al. Pre-operative MR mammography in breast cancer patients. Eur J Surg Oncol. 1999;25:142-145.
6. Essermann L, Hylton N, Yassa L, et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol. 1999;17:110-119.
7. Warner E, Plewes DB, Shumak RS, et al. Comparison of breast magnetic resonance imaging, mammography and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol. 2001;19: 3524-3531.
8. Mumtaz H, Hall-Craggs MA, Davidson T, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol. 1997; 169:417-424.
9. Piccoli CW. Contrast-enhanced breast MRI: factors affecting sensitivity and specificity. Eur Radiol. 1997;7(suppl 5):S281-S288.
10. Hylton NM, Kinkel K. Technical aspects of breast magnetic resonance imaging. Top Magn Reson Imaging. 1998;9:3-16.
11. Liu PF, Debatin JF, Caduff RF, et al. Improved diagnostic accuracy in dynamic contrast-enhanced MRI of the breast by combined quantitative and qualitative analysis. Br J Radiol. 1998;71:501-509.
12. Heywang-Kobrunner SH. Contrast-enhanced magnetic resonance imaging of the breast. Invest Radiol. 1994;29:94-104.
13. Kuhl CK, Schild HH. Dynamic image interpretation of MRI of the breast. J Magn Reson Imag. 2000;12:965-974.
14. Kuhl CK, Mielcareck P, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology. 1999;211:101-110.
15. Hayton P, Brady M, Tarassenko L, et al. Analysis of dynamic MR breast images using a model of contrast enhancement. Med Image Anal. 1997;1:207-224.
16. Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imag. 1999;10:260-266.
17. Heywang-Kobrunner SH, Bick U, Bradley WG Jr, et al. International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol. 2001;11:531-546.
18. Neubauer H, Li M, Kuehne-Heid R, et al. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. Br J Radiol. 2003;76:3-12.
19. Stoutjesdijk MJ, Fütterer JJ, Boetes C, et al. Variability in the description of morphologic and contrast enhancement characteristics of breast lesions on magnetic resonance imaging. Invest Radiol. 2005;40:355-362.
20. Nelder JA, Mead RA. Simplex method for function minimization. Computer J. 1965;7:308-331.
21. Jackson VP, Hendrick RE, Feig SA, et al. Imaging of the radiographically dense breast. Radiology. 1993;188:297-301.
22. Khatri VP, Stuppino JJ, Espinosa MH, et al. Improved accuracy in differentiating malignant from benign mammographic abnormalities: a simple, improved magnetic resonance imaging method. Cancer. 2001; 92:471-478.
23. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of pre-operative contrast-enhanced MR imaging on the therapeutic approach. Radiology. 1999;213:881-888.
24. Kinkel K, Helbich TH, Esserman LJ, et al. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. AJR Am J Roentgenol. 2000;175:35-43.
25. Preda A, Turetschek K, Daldrup H, et al. The choice of region of interest measures in contrast-enhanced magnetic resonance image characterization of experimental breast tumors. Invest Radiol. 2005;40:349-354.
26. Agoston AA, Daniel BL, Herfkens RJ, et al. Intensity-modulated parametric mapping for simultaneous display of rapid dynamic and high-spatial-resolution breast MR. Imaging Data, Imaging & Therapeutic Technology. 2001;21:217-226.
27. Weinstein D, Strano S, Cohen P, et al. Breast fibroadenoma: mapping of pathophysiologic features with three-time-point, contrast-enhanced MR imaging-pilot study. Radiology. 1999;210:233-240.
28. Matsubayashi R, Matsuo Y, Edakuni G, et al. Breast masses with peripheral rim enhancement on dynamic contrast enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology. 2000;217:841-848.
29. Parker GJ, Suckling J, Tanner SF, et al. MRIW: parametric analysis software for contrast-enhanced dynamic MR imaging in cancer. Radiographics. 1998;18:497-506.
30. Hoffmann U, Brix G, Knopp MV, et al. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med. 1995;33:506-514.
31. Lucht R, Delorme D, Heiss J, et al. Classification of signal-time curves obtained by dynamic magnetic resonance mammography: statistical comparison of quantitative methods. Invest Radiol. 2005;40:442-447.
32. Jacobs MA, Barker PB, Bluemke DA, et al. Benign and malignant breast lesions: diagnosis with multiparametric MR imaging. Radiology. 2003; 229:225-232.
33. White-Nunes L, Schnall MD, Orel SG. Update of breast MR imaging architectural interpretation model. Radiology. 2001;219:484-494.
34. De Haën C, Cabrini M, Akhnana L, et al. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance): pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr. 1999;23(suppl 1):S161-S168.
35. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins: a new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol. 1997;32:780-796.
36. Pediconi F, Catalano C, Occhiato R, et al. Contrast-enhanced MR Mammography: Intra-individual crossover comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for breast lesion detection and characterization. Radiology. In press.
37. Parker GJ, Suckling J, Tanner SF, et al. Probing tumor microvascularity by measurement, analysis, and display of contrast agent uptake kinetics. J Magn Reson Imag. 1997;7:564-574.